Bortezomib could down-regulate the expression of RANKL, inhibit cell proliferation and induce cell apoptosis in the human myeloma cell line RPMI 8226 by activating casepase-3.
about
Bortezomib could down-regulate the expression of RANKL, inhibit cell proliferation and induce cell apoptosis in the human myeloma cell line RPMI 8226 by activating casepase-3.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Bortezomib could down-regulate ...... 8226 by activating casepase-3.
@en
type
label
Bortezomib could down-regulate ...... 8226 by activating casepase-3.
@en
prefLabel
Bortezomib could down-regulate ...... 8226 by activating casepase-3.
@en
P2093
P2860
P356
P1433
P1476
Bortezomib could down-regulate ...... 8226 by activating casepase-3.
@en
P2093
Pi-Sheng Zhang
Ren-Zhi Pei
Xiao-Hong Du
Xu-Hui Liu
Zhen-Fei Xiang
P2860
P304
P356
10.3233/CBM-170584
P577
2017-08-01T00:00:00Z